Mutual funds and ETFs with big asset weightings in biotech have been excelling in the stock market this year. The top three holdings of relatively broader-based ETF PowerShares Dynamic Pharmaceuticals ETF (PJP) include Gilead Sciences (GILD), according to Morningstar. A developer of treatments for HIV and hepatitis, Gilead is extended well beyond its latest basing formation.